{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:23:10Z","timestamp":1792174990910,"version":"4.4.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2019\/15873-6"],"award-info":[{"award-number":["2019\/15873-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["304091\/2021-9"],"award-info":[{"award-number":["304091\/2021-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Germline and somatic drivers are identified in 30% and 40% of pheochromocytomas and paragangliomas (PPGLs), respectively. In this study, we investigated the genetic landscape of PPGLs in a Brazilian cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied 182 index patients with PPGLs (116 females and 66 males), comprising 118 pheochromocytoma and 70 paraganglioma cases. Our optimized sequencing strategy included SANGER sequencing, targeted next-generation sequencing panel, and whole-exome sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Germline and somatic pathogenic or likely pathogenic variants in susceptibility genes were identified in 88 (48.4%) and 18 (10.4%) cases, respectively. SDHB was the most frequently affected gene, identified in 30 patients (16.5%), with a germline SDHB exon 1 deletion present in 46.7% of these cases. The Brazilian cohort exhibited a higher rate of germline diagnoses when compared to the European (31%), American (27%), and Chinese (21%) cohorts (P &amp;lt; .001). Five germline variants in new susceptibility genes were identified: (1) Three CHEK2 likely pathogenic or pathogenic variants (c.475T &amp;gt; C\/p.Tyr159His; c.362G &amp;gt; A\/p.Cys121Tyr; c.319 + 2T &amp;gt; A); and (2) Two BRCA2 pathogenic variants (c.3680_3681delTG\/p.Leu1227fs and c.7806-2A &amp;gt; C). These variants are unreported in the Brazilian genomic variant repository. CHEK2 immunostaining was negative in the three tumors, with one case exhibiting CHEK2 loss of heterozygosity. Moreover, the prevalence of CHEK2 or BRCA2 pathogenic or likely pathogenic variants in our cohort was significantly higher compared to global population databases (P &amp;lt; .0001 and P = .0004, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our cohort of PPGLs demonstrated a high frequency of germline diagnoses. Additionally, our findings suggest CHEK2 and BRCA2 as potential susceptibility genes for PPGLs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvae160","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T15:29:41Z","timestamp":1734103781000},"page":"1-14","source":"Crossref","is-referenced-by-count":9,"title":["Insights into the genetic landscape of pheochromocytomas and paragangliomas in a Brazilian cohort"],"prefix":"10.1093","volume":"192","author":[{"given":"Gustavo F C","family":"Fagundes","sequence":"first","affiliation":[{"name":"Unidade de Adrenal, Laborat\u00f3rio de Endocrinologia Molecular e Celular LIM25, Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Freitas-Castro","sequence":"additional","affiliation":[{"name":"Unidade de Adrenal, Laborat\u00f3rio de Endocrinologia Molecular e Celular LIM25, Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas S","family":"Santana","sequence":"additional","affiliation":[{"name":"Unidade de Adrenal, Laborat\u00f3rio de Endocrinologia Molecular e Celular LIM25, Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe L","family":"Ledesma","sequence":"additional","affiliation":[{"name":"Divis\u00e3o de Anatomia Patol\u00f3gica, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 05403-010 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaina","family":"Petenuci","sequence":"additional","affiliation":[{"name":"Unidade de Adrenal, Laborat\u00f3rio de Endocrinologia Molecular e Celular LIM25, Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Caroline F","family":"Afonso","sequence":"additional","affiliation":[{"name":"Divis\u00e3o de Anatomia Patol\u00f3gica, Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP), Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio A A","family":"Pereira","sequence":"additional","affiliation":[{"name":"Unidade de Adrenal, Laborat\u00f3rio de Endocrinologia Molecular e Celular LIM25, Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Alice W","family":"Maciel","sequence":"additional","affiliation":[{"name":"Unidade de Adrenal, Laborat\u00f3rio de Endocrinologia Molecular e Celular LIM25, Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibere C","family":"Soares","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Horm\u00f4nios e Gen\u00e9tica Molecular LIM\/42 e Laborat\u00f3rio de Sequenciamento em Larga Escala (SELA), Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia L","family":"Gomes","sequence":"additional","affiliation":[{"name":"Divis\u00e3o de Endocrinologia, Santa Casa de Belo Horizonte , Belo Horizonte 30150-221 ,","place":["Brazil"]},{"name":"Departmento de Medicina Interna, Faculdade de Medicina, Universidade Federal de Minas Gerais , Belo Horizonte 30130-100 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delmar M","family":"Louren\u00e7o","sequence":"additional","affiliation":[{"name":"Unidade de Adrenal, Laborat\u00f3rio de Endocrinologia Molecular e Celular LIM25, Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]},{"name":"Unidade de Oncologia End\u00f3crina, Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP), Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adelaide A","family":"Pereira","sequence":"additional","affiliation":[{"name":"Divis\u00e3o de Anatomia Patol\u00f3gica, Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP), Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8346-3833","authenticated-orcid":false,"given":"Victor","family":"Srougi","sequence":"additional","affiliation":[{"name":"Divis\u00e3o de Urologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 05403-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Y","family":"Tanno","sequence":"additional","affiliation":[{"name":"Divis\u00e3o de Urologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 05403-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L","family":"Chambo","sequence":"additional","affiliation":[{"name":"Divis\u00e3o de Urologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 05403-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Candida B V","family":"Fragoso","sequence":"additional","affiliation":[{"name":"Divis\u00e3o de Anatomia Patol\u00f3gica, Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP), Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-000 ,","place":["Brazil"]},{"name":"Unidade de Oncologia End\u00f3crina, Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP), Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana O","family":"Hoff","sequence":"additional","affiliation":[{"name":"Unidade de Oncologia End\u00f3crina, Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP), Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice B","family":"Mendonca","sequence":"additional","affiliation":[{"name":"Divis\u00e3o de Anatomia Patol\u00f3gica, Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP), Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Claudia","family":"Latronico","sequence":"additional","affiliation":[{"name":"Unidade de Adrenal, Laborat\u00f3rio de Endocrinologia Molecular e Celular LIM25, Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2957-6148","authenticated-orcid":false,"given":"Madson Q","family":"Almeida","sequence":"additional","affiliation":[{"name":"Unidade de Adrenal, Laborat\u00f3rio de Endocrinologia Molecular e Celular LIM25, Divis\u00e3o de Endocrinologia e Metabologia, Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-903 ,","place":["Brazil"]},{"name":"Unidade de Oncologia End\u00f3crina, Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo (ICESP), Faculdade de Medicina da Universidade de S\u00e3o Paulo , S\u00e3o Paulo 01246-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"issue":"8","key":"2026041420244367500_lvae160-B1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"issue":"6","key":"2026041420244367500_lvae160-B2","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026041420244367500_lvae160-B3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"issue":"2","key":"2026041420244367500_lvae160-B4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccell.2017.01.009","article-title":"Pheochromocytomas and paragangliomas, genetically diverse and minimalist, all at once!","volume":"31","author":"Dahia","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"2026041420244367500_lvae160-B5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"4","key":"2026041420244367500_lvae160-B6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"NGS in PPGL (NGSnPPGL) Study Group","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2026041420244367500_lvae160-B7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"Nolting","year":"2022","journal-title":"Endocr Rev"},{"issue":"6","key":"2026041420244367500_lvae160-B8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr Rev"},{"issue":"6","key":"2026041420244367500_lvae160-B9","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1210\/jc.2018-01968","article-title":"Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-prono study): a European network for the study of adrenal tumors retrospective study","volume":"104","author":"Hescot","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2026041420244367500_lvae160-B10","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2026041420244367500_lvae160-B11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","article-title":"Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators","volume":"96","author":"Ayala-Ramirez","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2026041420244367500_lvae160-B12","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cancers11101505","article-title":"Current management of pheochromocytoma\/paraganglioma: a guide for the practicing clinician in the era of precision medicine","volume":"11","author":"N\u00f6lting","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2026041420244367500_lvae160-B13","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat Commun"},{"key":"2026041420244367500_lvae160-B14","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun"},{"issue":"7","key":"2026041420244367500_lvae160-B15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2026041420244367500_lvae160-B16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/jc.2018-02411","article-title":"Positive impact of genetic test on the management and outcome of patients with paraganglioma and\/or pheochromocytoma","volume":"104","author":"Buffet","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026041420244367500_lvae160-B17","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1210\/clinem\/dgaa502","article-title":"Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma","volume":"105","author":"Jiang","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2026041420244367500_lvae160-B18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"5","key":"2026041420244367500_lvae160-B19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1210\/clinem\/dgac677","article-title":"TNM staging and overall survival in patients with pheochromocytoma and sympathetic paraganglioma","volume":"108","author":"Jimenez","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026041420244367500_lvae160-B20","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1210\/clinem\/dgad028","article-title":"Evidence for a founder effect of SDHB Exon 1 deletion in Brazilian patients with paraganglioma","volume":"108","author":"Fagundes","year":"2023","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2026041420244367500_lvae160-B21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"23","key":"2026041420244367500_lvae160-B22","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen\u2013the clinical genome resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"2026041420244367500_lvae160-B23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.gim.2022.01.001","article-title":"Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)","volume":"24","author":"Horak","year":"2022","journal-title":"Genet Med"},{"issue":"4","key":"2026041420244367500_lvae160-B24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2026041420244367500_lvae160-B25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"9","key":"2026041420244367500_lvae160-B26","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","author":"Toledo","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2026041420244367500_lvae160-B27","doi-asserted-by":"publisher","first-page":"E173","DOI":"10.1002\/humu.20826","article-title":"Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations","volume":"29","author":"Pros","year":"2008","journal-title":"Hum Mutat"},{"issue":"6","key":"2026041420244367500_lvae160-B28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/1479-7364-5-6-623","article-title":"Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis","volume":"5","author":"Laycock-van Spyk","year":"2011","journal-title":"Hum Genomics"},{"issue":"1","key":"2026041420244367500_lvae160-B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40246-017-0109-3","article-title":"The NF1 somatic mutational landscape in sporadic human cancers","volume":"11","author":"Philpott","year":"2017","journal-title":"Hum Genomics"},{"issue":"1","key":"2026041420244367500_lvae160-B30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13023-019-1196-0","article-title":"Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75 patients","volume":"14","author":"Zhu","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2026041420244367500_lvae160-B31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1530\/ERC-13-0101","article-title":"In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas","volume":"20","author":"Toledo","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2026041420244367500_lvae160-B32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/ERC-13-0384","article-title":"Frequent EPAS1\/HIF2\u03b1 exons 9 and 12 mutations in non-familial pheochromocytoma","volume":"21","author":"Welander","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"2026041420244367500_lvae160-B33","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis","volume":"22","author":"Comino-Mendez","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2026041420244367500_lvae160-B34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/gcc.22347","article-title":"HRAS mutation prevalence and associated expression patterns in pheochromocytoma","volume":"55","author":"Stenman","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"2026041420244367500_lvae160-B35","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1530\/EC-21-0300","article-title":"Composite pheochromocytoma\/paraganglioma-ganglioneuroma: analysis of SDH and ATRX status, and identification of frequent HRAS and BRAF mutations","volume":"10","author":"Chen","year":"2021","journal-title":"Endocr Connect"},{"issue":"2","key":"2026041420244367500_lvae160-B36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00268-017-4320-0","article-title":"Activating FGFR1 mutations in sporadic pheochromocytomas","volume":"42","author":"Welander","year":"2018","journal-title":"World J Surg"},{"issue":"3","key":"2026041420244367500_lvae160-B37","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1136\/jmg.40.3.e31","article-title":"High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil","volume":"40","author":"Rocha","year":"2003","journal-title":"J Med Genet"},{"issue":"2","key":"2026041420244367500_lvae160-B38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1897-4287-2-2-93","article-title":"Mutations in the von Hippel-Lindau tumour suppressor gene in central nervous system hemangioblastomas","volume":"2","author":"Cybulski","year":"2004","journal-title":"Hered Cancer Clin Pract"},{"issue":"20","key":"2026041420244367500_lvae160-B39","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"13","key":"2026041420244367500_lvae160-B40","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1056\/NEJMc1716652","article-title":"EPAS1 mutations and paragangliomas in cyanotic congenital heart disease","volume":"378","author":"Vaidya","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"2026041420244367500_lvae160-B41","doi-asserted-by":"publisher","first-page":"a006090","DOI":"10.1101\/mcs.a006090","article-title":"Common clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline","volume":"7","author":"Bazinet","year":"2021","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"1","key":"2026041420244367500_lvae160-B42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10549-007-9838-7","article-title":"Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations","volume":"112","author":"Kleibl","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2026041420244367500_lvae160-B43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10689-017-0011-0","article-title":"Potentially pathogenic germline CHEK2 c.319 + 2T &gt; A among multiple early-onset cancer families","volume":"17","author":"Dominguez-Valentin","year":"2018","journal-title":"Fam Cancer."},{"issue":"2","key":"2026041420244367500_lvae160-B44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10549-007-9868-1","article-title":"Genetic analysis of BRCA1 and BRCA2 in breast\/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1","volume":"112","author":"Miramar","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2026041420244367500_lvae160-B45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/cge.12441","article-title":"The role of targeted BRCA1\/BRCA2 mutation analysis in hereditary breast\/ovarian cancer families of Portuguese ancestry","volume":"88","author":"Peixoto","year":"2015","journal-title":"Clin Genet"},{"issue":"3","key":"2026041420244367500_lvae160-B46","doi-asserted-by":"publisher","first-page":"E1200","DOI":"10.1002\/humu.21202","article-title":"Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study","volume":"31","author":"Borg","year":"2010","journal-title":"Hum Mutat"},{"issue":"10","key":"2026041420244367500_lvae160-B47","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/jmg.2004.029538","article-title":"Splicing in action: assessing disease causing sequence changes","volume":"42","author":"Baralle","year":"2005","journal-title":"J Med Genet"},{"issue":"2","key":"2026041420244367500_lvae160-B48","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1530\/ERC-17-0286","article-title":"TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias","volume":"25","author":"Asprino","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026041420244367500_lvae160-B49","doi-asserted-by":"publisher","first-page":"999329","DOI":"10.3389\/fgene.2022.999329","article-title":"SDHB exon 1 deletion: a recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas","volume":"13","author":"Manotas","year":"2022","journal-title":"Front Genet"},{"issue":"2","key":"2026041420244367500_lvae160-B50","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1210\/clinem\/dgad515","article-title":"Asymmetric adrenals: sexual dimorphism of adrenal tumors","volume":"109","author":"Bechmann","year":"2024","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2026041420244367500_lvae160-B51","doi-asserted-by":"publisher","first-page":"bvae038","DOI":"10.1210\/jendso\/bvae038","article-title":"Patient sex and origin influence distribution of driver genes and clinical presentation of paraganglioma","volume":"8","author":"Richter","year":"2024","journal-title":"J Endocr Soc"},{"issue":"12","key":"2026041420244367500_lvae160-B52","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3390\/cells9122675","article-title":"CHEK2 germline variants in cancer predisposition: stalemate rather than checkmate","volume":"9","author":"Stolarova","year":"2020","journal-title":"Cells"},{"issue":"9","key":"2026041420244367500_lvae160-B53","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.trecan.2022.04.009","article-title":"CHEK2 variants: linking functional impact to cancer risk","volume":"8","author":"Boonen","year":"2022","journal-title":"Trends Cancer"},{"key":"2026041420244367500_lvae160-B54","doi-asserted-by":"publisher","first-page":"1392386","DOI":"10.1155\/2021\/1392386","article-title":"Recurrent germline mutations of CHEK2 as a new susceptibility gene in patients with pheochromocytomas and paragangliomas","volume":"2021","author":"Gao","year":"2021","journal-title":"Int J Endocrinol"},{"key":"2026041420244367500_lvae160-B55","doi-asserted-by":"publisher","first-page":"1024108","DOI":"10.3389\/fendo.2022.1024108","article-title":"Case report: Two sisters with a germline CHEK2 variant and distinct endocrine neoplasias","volume":"13","author":"Vallera","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"17","key":"2026041420244367500_lvae160-B56","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1093\/hmg\/ddac089","article-title":"Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases","volume":"31","author":"Yngvadottir","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"11","key":"2026041420244367500_lvae160-B57","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","article-title":"Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer","volume":"91","author":"Peto","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2026041420244367500_lvae160-B58","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2026041420244367500_lvae160-B59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10689-006-0009-5","article-title":"BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast\/ovarian cancer families","volume":"5","author":"Peixoto","year":"2006","journal-title":"Fam Cancer"},{"issue":"55","key":"2026041420244367500_lvae160-B60","doi-asserted-by":"publisher","first-page":"30649","DOI":"10.18632\/oncotarget.25769","article-title":"Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers","volume":"9","author":"Chan","year":"2018","journal-title":"Oncotarget"},{"key":"2026041420244367500_lvae160-B61","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2407-8-140","article-title":"Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and\/or ovarian cancer","volume":"8","author":"Machackova","year":"2008","journal-title":"BMC Cancer"},{"issue":"3","key":"2026041420244367500_lvae160-B62","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1101\/gad.14.3.278","article-title":"Chk2\/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53","volume":"14","author":"Chehab","year":"2000","journal-title":"Genes Dev"},{"key":"2026041420244367500_lvae160-B63","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2026041420244367500_lvae160-B64","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ncb2763","article-title":"Signal integration by mTORC1 coordinates nutrient input with biosynthetic output","volume":"15","author":"Dibble","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"8","key":"2026041420244367500_lvae160-B65","doi-asserted-by":"publisher","first-page":"e1006242","DOI":"10.1371\/journal.pgen.1006242","article-title":"Whole exome sequencing identifies TSC1\/TSC2 biallelic loss as the primary and sufficient driver event for renal angiomyolipoma development","volume":"12","author":"Giannikou","year":"2016","journal-title":"PLoS Genet"},{"issue":"1","key":"2026041420244367500_lvae160-B66","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1677\/ERC-08-0142","article-title":"Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review","volume":"16","author":"Dworakowska","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2026041420244367500_lvae160-B67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.aace.2023.12.001","article-title":"A woman with bilateral pheochromocytoma and tuberous sclerosis complex","volume":"10","author":"Zahid","year":"2024","journal-title":"AACE Clin Case Rep"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvae160\/61217132\/lvae160.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/1\/1\/61217132\/lvae160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/1\/1\/61217132\/lvae160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:48:28Z","timestamp":1776214108000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/192\/1\/1\/7926799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvae160","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,12,17]]}}}